GlassScriptPhysician profile
Scott C Swenson
NPI 1861546764
$1,744.72
in general payments reported to CMS, 2019-2025
14 companies · $455 in 2025
The $455 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $23.76 · 2021: $88.27 · 2022: $107 · 2023: $464 · 2024: $378 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,297.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $762.61 | 2019-2025 | Sapien 3 Ultra Resilia, Hemosphere |
| Boston Scientific Corporation | $231.49 | 2024-2025 | Wavewriter Alpha Prime 16, Sentinel |
| Merck Sharp & Dohme LLC | $163.00 | 2021-2024 | Bridion |
| Haemonetics Corporation | $146.71 | 2023-2025 | Teg6s Hemostasis System |
| Pacira Pharmaceuticals Incorporated | $137.86 | 2022-2025 | Exparel |
| Chiesi USA, INC. | $62.71 | 2022-2025 | Cleviprex |
| Cardiovascular Systems INC. | $54.77 | 2019-2023 | Diamondback Coronary |
| Trevena, INC. | $42.02 | 2021 | |
| Mallinckrodt Enterprises LLC | $27.13 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $26.41 | 2025 | |
| Mindray Ds USA, INC. | $23.95 | 2023 | A7 Anesthesia System |
| Astrazeneca Pharmaceuticals LP | $23.76 | 2020 | |
| Heron Therapeutics, INC. | $22.53 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.77 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Swenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.